A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

Darbepoetin alfa is a novel erythropoiesis stimulating protein (NESP), which stimulates erythropoiesis by the same mechanism as recombinant human erythropoietin (rHuEPO). NESP has been shown to be safe and efficacious in patients with chronic renal failure. NESP is biochemically distinct from rHuEPO...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaspy, J, Jadeja, J Singh, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, Rigas, J, Kuter, D, Harmon, D, Prow, D, Demetri, G, Gordon, D, Arseneau, J, Saven, A, Hynes, H, Boccia, R, O'Byrne, J, Colowick, A B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363898/
https://www.ncbi.nlm.nih.gov/pubmed/11308270
http://dx.doi.org/10.1054/bjoc.2001.1748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363898/
https://www.ncbi.nlm.nih.gov/pubmed/11308270
http://dx.doi.org/10.1054/bjoc.2001.1748

Ejemplares similares